Dr. Omar M. Mahmoud, MD

Dr. Mahmoud practices at Baptist MD Anderson Cancer Physicians in Jacksonville, Florida.

Dr. Mahmoud's NPI, 1467784439, was assigned on February 2, 2010. Dr. Mahmoud graduated from Cairo University School of Medicine in 2001. Dr. Mahmoud holds Florida license ME114209.

Dr. Mahmoud's primary practice is Baptist MD Anderson Cancer Physicians, at 1301 Palm Ave, Jacksonville, FL 32207 in Duval County. The practice phone is (904) 202-7300.

Dr. Mahmoud's primary practice is Baptist MD Anderson Cancer Physicians in Jacksonville, Florida. Dr. Mahmoud is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Baptist MD Anderson Cancer Physicians. Dmand AI also links Dr. Mahmoud to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahmoud practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Mahmoud's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Mahmoud is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Mahmoud's licenses on file in 4 states: Florida, California, North Carolina and New Jersey.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Mahmoud treats.

CMS data shows 2,346 Medicare services from Dr. Mahmoud across 14 procedure codes in 2024, for 353 Medicare patients. Medicare paid $180,536 for them.

CMS counts 353 Medicare patients who saw Dr. Mahmoud in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mahmoud's median patient age at 73, with 27% women.

In 2024, Dr. Mahmoud wrote 256 Medicare Part D claims for 73 patients. 98% of them were for generic drugs. CMS names the drug for 196 of them, across 4 drugs with 11 or more claims each, at $3,029 in total drug cost. In 2023, CMS named 169 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Mahmoud for performance year 2024, reported as part of a group. Dr. Mahmoud accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mahmoud as offering telehealth.

Dmand AI links 61 papers to Dr. Mahmoud, published from 2009 to 2024. 2017 was the busiest year, with 14. The most frequent topics are Radiotherapy, Adjuvant, Carcinoma, Squamous Cell and Neoadjuvant Therapy. Dr. Mahmoud has published most often in Dermatol Ther (Heidelb). Dr. Mahmoud's most frequent co-authors are Gil Yosipovitch, MD, Ravi Jayendra Chokshi, MD and Soly Baredes, MD.

Dmand AI links Dr. Mahmoud to 1 clinical trial. Conditions studied include Carcinoma.

CMS Open Payments shows 10 general payments to Dr. Mahmoud from 5 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 38% of the total. Siemens Medical Solutions USA, Inc. paid the most, $309.

Dr. Mahmoud graduated from Cairo University School of Medicine in 2001.

Dr. Mahmoud is in network with 14 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.